Just read this article but I am not sure if this is the solution...
Health - Reuters
Pfizer Not Moving Ahead with Viagra for Women
Reuters
Fri Feb 27, 6:37 PM ET
Add Health - Reuters to My Yahoo!
NEW YORK (Reuters) - Pfizer Inc. on Friday said it was unable to prove that its impotence drug Viagra was effective in treating women, and it would not seek regulatory approval for it as a treatment for female sexual arousal disorder.
"Female sexual arousal disorder (FSAD) is an emerging area of research and is far more complex than male erectile dysfunction," Dr. Joe Feczko, Pfizer's president of worldwide development, said in a statement.
The world's largest drug company has enjoyed tremendous success with its famous blue pill for erectile dysfunction in men since its 1998 launch, racking up worldwide annual sales of nearly $2 billion.
A successful version for women could potentially have doubled sales.
Pfizer said it began studying Viagra for use in women in 1996 and has conducted several large-scale studies involving about 3,000 patients.
While the drug was found to be safe in all studies, Pfizer said, data on its effectiveness in treating sexual arousal problems in women did not support submitting the drug for review by the U.S. Food and Drug Administration (news - web sites).
Pfizer said it would end the program this month.
"Diagnosing FSAD involves assessing physical, emotional and relationship factors, and these complex and interdependent factors make measuring a medicine's effect very difficult," Feczko added.
Several drug makers have been trying to develop a so-called female Viagra in hopes of establishing an enormous untapped market.
Analysts have said that any drugs for female sexual dysfunction that prove effective in treating problems with arousal, diminished desire or inability to achieve orgasm could garner sales of well over $1 billion a year.
PS
http://story.news.yahoo.com/news?tmp...izer_viagra_dc
Health - Reuters
Pfizer Not Moving Ahead with Viagra for Women
Reuters
Fri Feb 27, 6:37 PM ET
Add Health - Reuters to My Yahoo!
NEW YORK (Reuters) - Pfizer Inc. on Friday said it was unable to prove that its impotence drug Viagra was effective in treating women, and it would not seek regulatory approval for it as a treatment for female sexual arousal disorder.
"Female sexual arousal disorder (FSAD) is an emerging area of research and is far more complex than male erectile dysfunction," Dr. Joe Feczko, Pfizer's president of worldwide development, said in a statement.
The world's largest drug company has enjoyed tremendous success with its famous blue pill for erectile dysfunction in men since its 1998 launch, racking up worldwide annual sales of nearly $2 billion.
A successful version for women could potentially have doubled sales.
Pfizer said it began studying Viagra for use in women in 1996 and has conducted several large-scale studies involving about 3,000 patients.
While the drug was found to be safe in all studies, Pfizer said, data on its effectiveness in treating sexual arousal problems in women did not support submitting the drug for review by the U.S. Food and Drug Administration (news - web sites).
Pfizer said it would end the program this month.
"Diagnosing FSAD involves assessing physical, emotional and relationship factors, and these complex and interdependent factors make measuring a medicine's effect very difficult," Feczko added.
Several drug makers have been trying to develop a so-called female Viagra in hopes of establishing an enormous untapped market.
Analysts have said that any drugs for female sexual dysfunction that prove effective in treating problems with arousal, diminished desire or inability to achieve orgasm could garner sales of well over $1 billion a year.
PS
http://story.news.yahoo.com/news?tmp...izer_viagra_dc
Suppose next im gunna find out they all dont charge either.
Comment